Bloomios, Inc.
BLMS
$0.001
-$0.0002-16.67%
| Weiss Ratings | BLMS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | BLMS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BLMS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -1.30 | |||
| Price History | BLMS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -13.33% | |||
| 30-Day Total Return | -35.00% | |||
| 60-Day Total Return | -62.86% | |||
| 90-Day Total Return | -59.38% | |||
| Year to Date Total Return | -50.00% | |||
| 1-Year Total Return | -99.84% | |||
| 2-Year Total Return | -99.92% | |||
| 3-Year Total Return | -99.94% | |||
| 5-Year Total Return | -99.72% | |||
| 52-Week High % Change | -99.85% | |||
| 52-Week Low % Change | 200.00% | |||
| Price | BLMS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.84 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Apr 03, 2024 | |||
| 52-Week High Price (Date) | Apr 21, 2023 | |||
| Valuation | BLMS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 77.37K | |||
| Enterprise Value | 33.16M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.30 | |||
| Earnings Per Share Growth | 231.27% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.01 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 4.03 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -6.85 | |||
| Enterprise Value/EBIT | -6.52 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BLMS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 61.47M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BLMS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 805 222 6330 | |||
| Address | 701 Anacapa Street Santa Barbara, CA 93101 | |||
| Website | www.bloomios.com | |||
| Country | United States | |||
| Year Founded | 2001 | |||
| Profitability | BLMS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -61.78% | |||
| Profit Margin | -489.86% | |||
| Management Effectiveness | BLMS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -122.75% | |||
| Return on Equity | -- | |||
| Income Statement | BLMS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 8.23M | |||
| Total Revenue (TTM) | 8.23M | |||
| Revenue Per Share | $0.13 | |||
| Gross Profit (TTM) | 2.05M | |||
| EBITDA (TTM) | -4.84M | |||
| EBIT (TTM) | -5.08M | |||
| Net Income (TTM) | -40.32M | |||
| Net Income Avl. to Common (TTM) | -40.32M | |||
| Total Revenue Growth (Q YOY) | -43.07% | |||
| Earnings Growth (Q YOY) | -1,139.21% | |||
| EPS Diluted (TTM) | -1.30 | |||
| EPS Diluted Growth (Q YOY) | -164.69% | |||
| Balance Sheet | BLMS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.20K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 346.50K | |||
| Total Preferred Equity (Q) | 8.50 | |||
| Total Equity (Q) | -31.46M | |||
| Current Ratio (Q) | 0.010 | |||
| Book Value Per Share (Q) | -$0.65 | |||
| Total Assets (Q) | 1.93M | |||
| Total Current Liabilities (Q) | 33.13M | |||
| Total Debt (Q) | 24.58M | |||
| Total Liabilities (Q) | 33.40M | |||
| Total Common Equity (Q) | -39.96M | |||
| Cash Flow | BLMS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 668.30K | |||
| Cash from Financing (TTM) | 6.44M | |||
| Net Change in Cash (TTM) | -77.30K | |||
| Levered Free Cash Flow (TTM) | 5.39M | |||
| Cash from Operations (TTM) | -7.11M | |||
